54 filings
Page 2 of 3
8-K
apzwf4 91q1zoy71k
15 Sep 22
Entry into a Material Definitive Agreement
4:03pm
8-K
rvflpd855 6dav4vw
4 Aug 22
Exagen Inc. Reports Second Quarter 2022 Results
4:06pm
8-K
7xc a8x9r3fzpaj
21 Jun 22
Submission of Matters to a Vote of Security Holders
8:30am
8-K
xviybj1kbd
11 May 22
Exagen Inc. Reports First Quarter 2022 Results
4:05pm
8-K
dfm830 0i
28 Apr 22
Departure of Directors or Certain Officers
4:11pm
8-K
srsd28ojvmknivuxvzv
22 Mar 22
Exagen Inc. Reports Fourth Quarter and Full Year 2021 Results
4:05pm
8-K
17xo j2f0k
10 Jan 22
Regulation FD Disclosure
8:25am
8-K
wgpq7 nevq
10 Nov 21
Exagen Inc. Reports Third Quarter 2021 Results
4:05pm
8-K
pmw0o4 nz
25 Oct 21
Exagen Inc. Announces $27.2 Million Debt Refinancing
8:26am
8-K
z6u1yyin9va6uin
19 Oct 21
Entry into a Material Definitive Agreement
4:05pm
8-K
fi9w0yz
27 Aug 21
Entry into a Material Definitive Agreement
8:25am
8-K
egzr6v
9 Aug 21
Exagen Inc. Reports Second Quarter 2021 Results
4:05pm
8-K
odjwbe00j203lu
30 Jul 21
Exagen Appoints Ana Hooker to Board of Directors
8:25am
8-K
i9tik14l9
21 Jun 21
Submission of Matters to a Vote of Security Holders
8:30am
8-K
i4k187
11 May 21
Exagen Inc. Reports First Quarter 2021 Results
4:06pm
8-K
i1wnbfftlz2ix4p2ph5k
23 Mar 21
Exagen Inc. Announces Proposed Public Offering of Common Stock
4:16pm
8-K
g5s5irh32
22 Mar 21
Amendments to Articles of Incorporation or Bylaws
4:20pm
8-K
rdtvdwc
16 Mar 21
Exagen Inc. Reports Fourth Quarter and Full Year 2020 Results
4:07pm
8-K
as2of
11 Jan 21
Exagen Inc. Reports Preliminary Fourth Quarter 2020 Testing Results
7:00am
8-K
mnqa0nohyv t1ky
28 Dec 20
Entry into a Material Definitive Agreement
4:06pm